Cabot earnings were $425.0M for the trailing 12 months ending Jun 30, 2025, with -8.6% growth year over year. The latest CBT earnings report on Jun 30, 2025 announced Q2 2025 earnings of $101.0M, up 7.4% from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, CBT reported annual earnings of $380.0M, with -14.6% growth.
CBT past earnings growth
How has CBT's earnings growth performed historically?
On CBT's earnings call on Invalid Date, Cabot (NYSE: CBT) reported Q2 2025 earnings per share (EPS) of $1.87, up 4.59% year over year. Total CBT earnings for the quarter were $101.00 million. In the same quarter last year, Cabot's earnings per share (EPS) was $1.96.
As of the last Cabot earnings report, Cabot is currently profitable. Cabot's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $425.00 million, a 10.9% decrease year over year.
What was CBT's earnings growth in the past year?
As of Cabot's earnings date in Invalid Date, Cabot's earnings has grown -8.64% year over year. This is 14.7 percentage points lower than the US Specialty Chemicals industry earnings growth rate of 6.07%. CBT earnings in the past year totalled $425.00 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.